SCHEMBL21542032

SCHEMBL21542032

CC(C)Nc1nc(NCc2ccc(S(C)(=O)=O)cc2)c2ncccc2n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.52
ACHE P22303 3/20 0.52
APP P05067 2/20 0.52
CA1 P00915 3/20 0.50
CA2 P00918 3/20 0.50
CA9 Q16790 3/20 0.50
PTGS2 P35354 1/20 0.44
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 1/20 0.43
GPR39 O43194 1/20 0.43
NPR1 P16066 3/20 0.42
KDM1A O60341 1/20 0.42
CDK2 P24941 3/20 0.41
CDK5 Q00535 3/20 0.41
CLK1 P49759 1/20 0.41
RAB9A P51151 1/20 0.41
CDK5R1 Q15078 1/20 0.41
EGFR P00533 1/20 0.41
AURKA O14965 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21567223 0.84 ACHE (0.76) BCHEACHEAPPCA1CA2
SCHEMBL30092849 0.84 ACHE (0.76) BCHEACHEAPPCA1CA2
SCHEMBL21541998 0.83 BCHE (0.52) BCHEACHEAPPCA1CA2
SCHEMBL21542040 0.82 BCHE (0.46) BCHEACHEAPPNPR1CDK2
SCHEMBL21567262 0.82 BCHE (0.53) BCHEACHEAPPCA1CA2
SCHEMBL21542002 0.82 APP (0.53) BCHEACHEAPPNPR1EGFR
SCHEMBL30092878 0.82 BCHE (0.53) BCHEACHEAPPCA1CA2
SCHEMBL21542062 0.81 CDK2 (0.51) BCHEACHEAPPCA1CA2
SCHEMBL21542054 0.77 CA1 (0.51) BCHEACHEAPPCA1CA2
SCHEMBL30724687 0.73 GPR39 (0.56) CA1CA2CA9PTGS2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2026-02-10 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-11518760-B2 Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2022-12-06 US disclosed
US-20190345157-A1 COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-11-14 US disclosed
US-20190345157-A1 COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds CBR1, CBR3, COX6C BCHE 2784/4885ACHE 2483/4885APP 4837/4885
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS PWWP2B, WARS1, PNPO BCHE 3860/4885ACHE 1710/4885APP 3897/4885
US-20190345157-A1 COMPOUNDS ABCB11, LTC4S, AQP1 BCHE 632/4885ACHE 297/4885APP 2829/4885
US-11518760-B2 Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds P2RX5, PNPO, P2RX3 BCHE 3579/4885ACHE 1142/4885APP 4242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.